期刊文献+

经皮冠状动脉介入治疗术后急性、亚急性支架内血栓形成的危险因素分析 被引量:33

Risk Factor Analysis of Acute and Sub-Acute In-Stent Thrombosis in Patients AfterPercutaneous Coronary Intervention Treatment
下载PDF
导出
摘要 目的:探讨经皮冠状动脉(冠脉)介入治疗(PCI)后急性、亚急性支架内血栓形成(AST/SST)的危险因素及其冠脉造影特点,以早期识别高危患者并减少该并发症的发生。方法:回顾性分析2007-01至2011-01收治的冠心病行PCI术者5 129例的临床资料,其中冠脉造影证实AST/SST(AST/SST组)43例。按年龄、性别(3∶1)匹配原则抽取PCI术后未出现AST/SST者120例作为对照组。采用logistic回归模型分析AST/SST的独立危险因素。结果:AST/SST平均时间(4.1±5.7)d。院内死亡率13.95%(6/43)。AST/SST组糖尿病比例及血肌酐、空腹血糖高于对照组(P<0.05);AST/SST组支架置入前1周内心绞痛发作及1个月内急性心肌梗死史比例均高于对照组(P<0.05、<0.01),差异均有统计学意义。左心室射血分数、血压、血脂等各项指标差异均无统计学意义。冠脉造影AST/SST组出现B2/C病变比例、支架贴壁不良比例和支架数目均高于对照组,差异均有统计学意义(P<0.05~0.01)。应用条件lo-gistic回归分析确定PCI术后AST/SST的独立危险因素:糖尿病(比值比1.447,95%可信区间1.101~1.902,P=0.008)、急性心肌梗死(比值比7.177,95%可信区间1.956~26.328,P=0.003)、多支架置入(比值比2.186,95%可信区间1.326~3.604,P=0.002)、支架贴壁不良(比值比7.590,95%可信区间1.389~41.475,P=0.019)是AST/SST的独立危险因素,高左心室射血分数(比值比0.988,95%可信区间0.979~0.998,P=0.016)是PCI术后并发AST/SST的保护因素(P均<0.05)。结论:糖尿病、急性心肌梗死、多支架置入、支架贴壁不良是PCI术后并发AST/SST的独立危险因素。高左心室射血分数是PCI术后并发AST/SST的保护因素。 Objective:To analyze the risk factor of acute/sub-acute stentt thrombosis(AST/SST) in patients after percutaneous coronary intervention(PCI) in order to identify the high risk patients at early stage and to reduce such complication. Methods:We retrospectively reviewed 5129 coronary artery disease(CAD) patients undergoing PCI who admitted in our hos- pital from 2007 to 2011. Our work included 2 groups. AST/SST group,n=43 ,the patients with coronary angiography(CAG) con- firmed lesions, and Control group, n = 120, the patients with matched age and gender(3 : 1 ), and the patients had no AST/SST after PCL Logistic regression analysis was performed to identify the independent risk factors of AST/SST. Resuhs :AST/SST occurred at a median of(4. 1 ±5.7 )days after symptom onset, the in hospital mortality was 13.95% (6/ 43 ). Compared with Control group, AST/SST group had more diabetes mellitus, higher serum creatinine and fasting blood surger, all P〈0. 05. The occurrence of angina and AMI at 1 week and lmonth before stent implantation were higher in AST/SST group,P 〈0. 05 and P〈0. 01. Left ventricular ejection fraction (LVEF), blood pressure and blood lipids were similar in both groups, P〉0. 05. CAG presented that AST/SST group had more B2/C lesion, stent real-apposition and stent number,P〈0.05 -0.01. Logistic regression analysis indicated that the independent risk factors for AST/SST included diabetes mellitus (OR: 1. 447,95% CI: 1.101 - 1. 902, P = 0. 008 ), AMI ( OR : 7.177,95 % CI : 1. 956 - 26. 328, P = 0. 003 ), more stent number ( OR: 2. 186,95 % CI : 1. 326 -3. 604,P=0. 002) and stent mal-apposition( OR:7. 590,95% CI:1. 389 -al. 475 ,P=0. 019). High LVEF is a protec- tive factor for AST/SST(OR:0. 988,95% CI:0. 979 -0. 998,P=0. 016) occurrence after PCI. Conclusion: Diabetes mellitus, AMI, more stent number, stent mal-apposition are independent risk factors for AST/SST occurrence in CAD patients after PCI treatment. High LVEF is a protective factor for AST/SST complication.
出处 《中国循环杂志》 CSCD 北大核心 2013年第1期17-20,共4页 Chinese Circulation Journal
关键词 经皮冠状动脉介入治疗 支架内血栓 危险因素 Percutaneous coronary intervention Stent thrombosis Risk factor
  • 相关文献

参考文献17

  • 1de la Torre-Hernandez JM, Alfonso F, Hernandez F, et al. Drug-eluting stent thrombosis:results from the multicenter Spanish registry ESTRO- FA. J Am Coil Cardiol,2008 ,51:986-990.
  • 2Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coro- nary stent trials: a case for standardized definations. Circiulation, 2007,115:2344-2351.
  • 3中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华高血压杂志,2010,19(6):701-712.
  • 4中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,:35-413,390.
  • 5杜润,张瑞岩.晚期支架贴壁不良研究进展[J].国际心血管病杂志,2008,35(6):353-356. 被引量:4
  • 6Palmerini T, Dangas G, Mehran R, et al. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syn- dromes : the ACUITY TriM. Circ Cardiovasc Interv ,2011,4:577-584.
  • 7Kimura T, Morimoto T, Kozuma K, et al. Comparisons of baseline de- mographics, clinical presentation, and long-term outcome among pa- tients with early,late, and very late stent thrombosis of sirolimus-elu- ring stents : Observations from the Registry of Stent Thrombosis for Re- view and Reevaluation(RESTART). Circulation ,2010,122:52-61.
  • 8Dangas GD, Caixeta A, Mehran R, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myo- cardial infarction. Circulation ,2011,123 : 1745-1756.
  • 9Heestermans AA, van Werkum JW, Zwart B, et al. Acute and subacute stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction : incidence, predictors and clinical outcome, j Thromb Haemost ,2010,8:2385-2393.
  • 10Kuchulakanti PK,Chu WW, Torguson R, et al. Correlates and long- term outcomes of angiographically proven stent thrombosis with siroli- mus-and paclitaxel-eluting stents. Circulation, 2006, 113 : 1108- 1113.

二级参考文献33

  • 1[1]Serruys PW,Daemen J.Are drug-eluting stems associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis,a nuisance in both bare metal and drug-eluting stems[J].Circulation,2007,115(11):1433-1439.
  • 2[2]Lüscher TF,Steffel J,Eberli FR,et al.Drug-eluting stent and coronary thrombosis:biological mechanisms and clinical implications[J].Circulation,2007,115(8):1051-1058.
  • 3[3]Ako J,Morino Y,Honda Y,et al.Late incomplete stent apposition after sirolimus-eluting stent implantation:a serial intravascular ultrasound analysis[J].J Am Coll Cardiol,2005,46(6);1002-1005.
  • 4[4]Siqueira DA,Abizaid AA,Costa Jde R,et al.Late incomplete apposition after drug-eluting stent implantation:incidence and potential for adverse clinical outcomes[J].Eur Heart J,2007,28(11):1304-1309.
  • 5[5]Shah VM,Mintz GS,Apple S,et al.Background incidence of late malapposition after bare-metal stem implantation[J].Circulation,2002,106(141:1753-1755.
  • 6[6]Hong MK,Mintz GS,Lee CW,et al.Incidence,mechanism,predictors,and long-term prognosis of late stem malapposition after hare-metal stem implantation[J].Circulation,2004,109(7):881-886.
  • 7[7]Okura H,Lee DP,Lo S,et al.Late incomplete apposition with excessive remodeling of the stented coronary artery following intravaseular brachytherapy[J].Am J Cardiol,2003,92(5):587-590.
  • 8[8]Kalinczuk L,Pregowski J,Mintz GS,et al.Incidence and mechanism of late stent malapposition after phosphorus-32 radioactive stent implantation[J].Am J Cardiol,2003,92(8):970-972.
  • 9[9]Serruys PW,Degertekin M,Tanabe K,et al.Intravascular ultrasound findings in the muhieenter,randomized,double-blind RAVEl.(RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial[J].Circulation,2002,106(71:798-803.
  • 10[10]Tanabe K,Serruys PW,Degertekin M,et al.TAXUS II Study Group.Incomplete stent apposition after implantation of paclitaxel-eluting stems or bare metal stems:insights from the randomized TAXUS II trial[J].Circulation,2005 111 (7):900-905.

共引文献64

同被引文献276

引证文献33

二级引证文献289

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部